Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04954001
Title Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
Principal Investigator Hans Gainesville Florida 32608 United States Details
John Hopkins All Children Hospital Saint Petersburg Florida 33701 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Medical University of South Carolina - Hollings Cancer Center - PPDS Charleston South Carolina 29425 United States Details
Research Site Beijing China Details
Research Site Guangzhou China Details
Research Site Hangzhou China Details
Research Site Shanghai China Details
Research Site Shijiazhuang China Details
Research Site Wuhan China Details
Hospital Universitario Vall d'Hebron Barcelona Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Hospital Universitario La Paz Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field